Intestinal proteomic analysis of a novel non-human primate model of experimental colitis reveals signatures of mitochondrial and metabolic dysfunction.


Journal

Mucosal immunology
ISSN: 1935-3456
Titre abrégé: Mucosal Immunol
Pays: United States
ID NLM: 101299742

Informations de publication

Date de publication:
11 2019
Historique:
received: 24 04 2019
accepted: 21 08 2019
revised: 15 08 2019
pubmed: 5 9 2019
medline: 28 4 2020
entrez: 5 9 2019
Statut: ppublish

Résumé

Animal models recapitulating features of chronic colitis, such as ulcerative colitis, Crohn's disease, or HIV infection, are critical to study disease pathogenesis and test novel therapeutics. In this study, we used a proteomics approach to explore the molecular intestinal response in two rhesus macaque (RM) animal models of experimentally induced colitis using dextran sulfate sodium (DSS) and simian immunodeficiency virus (SIV) infection. Proteomic analysis detected more than 2500 proteins in colonic tissue collected from 30 RMs. Differential protein expression analysis revealed a protein expression pattern in DSS-treated RMs resembling the proteome of human ulcerative colitis. In a group of 12 DSS-treated RMs compared to 6 with no treatment, decrease in expression of proteins related to mitochondrial energy metabolism, including fatty acid metabolism was noted, while innate immune activation pathways, including complement and coagulation proteins were upregulated. SIV infection of RMs resulted in increased innate immune responses related to viral defense. Proteomic signatures of barrier damage were apparent in both DSS treatment or SIV infection. These results demonstrate that DSS treatment in a non-human primate model resembles features of human ulcerative colitis, making this a promising tool to study important immunological mechanisms in inflammatory bowel disease.

Identifiants

pubmed: 31481749
doi: 10.1038/s41385-019-0200-2
pii: S1933-0219(22)00453-6
pmc: PMC7673647
mid: NIHMS1637079
doi:

Substances chimiques

Dextran Sulfate 9042-14-2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1327-1335

Subventions

Organisme : NIH HHS
ID : P51 OD011092
Pays : United States
Organisme : NIDDK NIH HHS
ID : K08 DK110415
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK112254
Pays : United States
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States

Références

Molodecky, N. A. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46–54 e42 (2012). quiz e30.
doi: 10.1053/j.gastro.2011.10.001
de Souza, H. S. & Fiocchi, C. Immunopathogenesis of IBD: current state of the art. Nat. Rev. Gastroenterol. Hepatol. 13, 13–27 (2016).
pubmed: 26627550 doi: 10.1038/nrgastro.2015.186
Baumgart, D. C. & Sandborn, W. J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369, 1641–1657 (2007).
pubmed: 17499606 doi: 10.1016/S0140-6736(07)60751-X
Kozuch, P. L. & Hanauer, S. B. Treatment of inflammatory bowel disease: a review of medical therapy. World J. Gastroenterol. 14, 354–377 (2008).
pubmed: 18200659 pmcid: 2679125 doi: 10.3748/wjg.14.354
DeVoss, J. & Diehl, L. Murine models of inflammatory bowel disease (IBD): challenges of modeling human disease. Toxicol. Pathol. 42, 99–110 (2014).
pubmed: 24231829 doi: 10.1177/0192623313509729
Estes, J. D. et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 6, e1001052 (2010).
pubmed: 20808901 pmcid: 2924359 doi: 10.1371/journal.ppat.1001052
Hao, X. P. et al. Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection. Nat. Commun. 6, 8020 (2015).
pubmed: 26282376 pmcid: 4544774 doi: 10.1038/ncomms9020
Fournier, B. M. & Parkos, C. A. The role of neutrophils during intestinal inflammation. Mucosal Immunol. 5, 354–366 (2012).
doi: 10.1038/mi.2012.24
Hodgson, H. J., Potter, B. J. & Jewell, D. P. Humoral immune system in inflammatory bowel disease: I. Complement levels. Gut 18, 749–753 (1977).
pubmed: 604196 pmcid: 1411653 doi: 10.1136/gut.18.9.749
Lam, G., Apostolopoulos, V., Zulli, A. & Nurgali, K. NADPH oxidases and inflammatory bowel disease. Curr. Med. Chem. 22, 2100–2109 (2015).
pubmed: 25876884 doi: 10.2174/0929867322666150416095114
Iwamoto, M., Koji, T., Makiyama, K., Kobayashi, N. & Nakane, P. K. Apoptosis of crypt epithelial cells in ulcerative colitis. J. Pathol. 180, 152–159 (1996).
pubmed: 8976873 doi: 10.1002/(SICI)1096-9896(199610)180:2<152::AID-PATH649>3.0.CO;2-Y
Shkoda, A. et al. Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease. J. Proteome Res. 6, 1114–1125 (2007).
pubmed: 17330946 doi: 10.1021/pr060433m
Barcelo-Batllori, S. et al. Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics 2, 551–560 (2002).
pubmed: 11987129 doi: 10.1002/1615-9861(200205)2:5<551::AID-PROT551>3.0.CO;2-O
Balasubramanian, K. et al. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Magn. Reson. Imaging 27, 79–86 (2009).
pubmed: 18599242 doi: 10.1016/j.mri.2008.05.014
Hsieh, S. Y. et al. Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics 6, 5322–5331 (2006).
pubmed: 16947118 doi: 10.1002/pmic.200500541
Fang, K. et al. Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis. Physiol. Genom. 43, 43–56 (2011).
doi: 10.1152/physiolgenomics.00138.2010
Gou, Y. et al. Ribosomal protein L6 promotes growth and cell cycle progression through upregulating cyclin E in gastric cancer cells. Biochem. Biophys. Res. Commun. 393, 788–793 (2010).
pubmed: 20171175 doi: 10.1016/j.bbrc.2010.02.083
Li, Y. et al. Relationship between ATM and ribosomal protein S6 revealed by the chemical inhibition of Ser/Thr protein phosphatase type 1. Biosci. Biotechnol. Biochem 76, 486–494 (2012).
pubmed: 22451389 doi: 10.1271/bbb.110774
Wirtz, S. et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat. Protoc. 12, 1295–1309 (2017).
pubmed: 28569761 doi: 10.1038/nprot.2017.044
Sifroni, K. G. et al. Mitochondrial respiratory chain in the colonic mucosal of patients with ulcerative colitis. Mol. Cell. Biochem. 342, 111–115 (2010).
pubmed: 20440543 doi: 10.1007/s11010-010-0474-x
Santhanam, S. et al. Mitochondrial electron transport chain complex dysfunction in the colonic mucosa in ulcerative colitis. Inflamm. Bowel Dis. 18, 2158–2168 (2012).
pubmed: 22374887 doi: 10.1002/ibd.22926
Roediger, W. E. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 2, 712–715 (1980).
pubmed: 6106826 doi: 10.1016/S0140-6736(80)91934-0
Chapman, M. A. et al. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 35, 73–76 (1994).
pubmed: 8307454 pmcid: 1374636 doi: 10.1136/gut.35.1.73
Sandler, N. G. et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601–605 (2014).
pubmed: 4418221 pmcid: 4418221 doi: 10.1038/nature13554
Geboes, K. et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47, 404–409 (2000).
pubmed: 10940279 pmcid: 1728046 doi: 10.1136/gut.47.3.404
Schniers, A. et al. The proteome of ulcerative colitis in colon biopsies from adults—optimized sample preparation and comparison with healthy controls. Proteom. Clin. Appl. 11, 11–12 (2017).
doi: 10.1002/prca.201700053
Naito, Y. et al. Identification of inflammation-related proteins in a murine colitis model by 2D fluorescence difference gel electrophoresis and mass spectrometry. J. Gastroenterol. Hepatol. 25, S144–S148 (2010).
pubmed: 20586857 doi: 10.1111/j.1440-1746.2009.06219.x
Cooney, J. M. et al. Proteomic analysis of colon tissue from interleukin-10 gene-deficient mice fed polyunsaturated fatty acids with comparison to transcriptomic analysis. J. Proteome Res. 11, 1065–1077 (2012).
pubmed: 22106967 doi: 10.1021/pr200807p
Johansson, M. E. et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63, 281–291 (2014).
pubmed: 23426893 doi: 10.1136/gutjnl-2012-303207
Sartor, R. B. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 390–407 (2006).
pubmed: 16819502 doi: 10.1038/ncpgasthep0528
Hermanowicz, A., Sliwinski, Z., Nawarska, Z. & Banas, B. Humoral immune system and ulcerative colitis activity. II. Complement level. Arch. Immunol. Ther. Exp. (Warsz.) 32, 509–514 (1984).
Teisberg, P. & Gjone, E. Humoral immune system activity in inflammatory bowel disease. Scand. J. Gastroenterol. 10, 545–549 (1975).
pubmed: 1171519
Sugihara, T. et al. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease. Clin. Exp. Immunol. 160, 386–393 (2010).
pubmed: 20089077 pmcid: 2883109 doi: 10.1111/j.1365-2249.2010.04093.x
Halstensen, T. S., Mollnes, T. E., Garred, P., Fausa, O. & Brandtzaeg, P. Surface epithelium related activation of complement differs in Crohn’s disease and ulcerative colitis. Gut 33, 902–908 (1992).
pubmed: 1379568 pmcid: 1379402 doi: 10.1136/gut.33.7.902
Imokawa, S. et al. Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis. Am. J. Respir. Crit. Care Med. 156, 631–636 (1997).
pubmed: 9279250 doi: 10.1164/ajrccm.156.2.9608094
Dhar, A. et al. Thrombin and factor Xa link the coagulation system with liver fibrosis. BMC Gastroenterol. 18, 60 (2018).
pubmed: 29739329 pmcid: 5941658 doi: 10.1186/s12876-018-0789-8
Henderson, N. C. et al. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat. Med. 19, 1617–1624 (2013).
pubmed: 24216753 doi: 10.1038/nm.3282
Reed, N. I. et al. The alphavbeta1 integrin plays a critical in vivo role in tissue fibrosis. Sci. Transl. Med. 7, 288ra279 (2015).
doi: 10.1126/scitranslmed.aaa5094
Chen, H. et al. Mechanosensing by the alpha6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis. Nat. Commun. 7, 12564 (2016).
pubmed: 27535718 pmcid: 4992155 doi: 10.1038/ncomms12564
Rieder, F. & Fiocchi, C. Intestinal fibrosis in IBD—a dynamic, multifactorial process. Nat. Rev. Gastroenterol. Hepatol. 6, 228–235 (2009).
pubmed: 19347014 doi: 10.1038/nrgastro.2009.31
Kugathasan, S. et al. Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study. Lancet 389, 1710–1718 (2017).
pubmed: 28259484 pmcid: 5719489 doi: 10.1016/S0140-6736(17)30317-3
Novak, E. A. & Mollen, K. P. Mitochondrial dysfunction in inflammatory bowel disease. Front. Cell Dev. Biol. 3, 62 (2015).
pubmed: 26484345 pmcid: 4589667 doi: 10.3389/fcell.2015.00062
Packiriswamy, N., Coulson, K. F., Holcombe, S. J. & Sordillo, L. M. Oxidative stress-induced mitochondrial dysfunction in a normal colon epithelial cell line. World J. Gastroenterol. 23, 3427–3439 (2017).
pubmed: 28596679 pmcid: 5442079 doi: 10.3748/wjg.v23.i19.3427
Roediger, W. E. & Nance, S. Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br. J. Exp. Pathol. 67, 773–782 (1986).
pubmed: 3099821 pmcid: 2013114
Hudert, C. A. et al. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl Acad. Sci. USA 103, 11276–11281 (2006).
pubmed: 16847262 doi: 10.1073/pnas.0601280103
Wiese, D. M. et al. Serum fatty acids Are correlated with inflammatory cytokines in ulcerative colitis. PLoS ONE 11, e0156387 (2016).
pubmed: 27227540 pmcid: 4882051 doi: 10.1371/journal.pone.0156387
De Preter, V. et al. Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway. Inflamm. Bowel Dis. 18, 1127–1136 (2012).
pubmed: 21987487 doi: 10.1002/ibd.21894
Veazey, R. S. et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280, 427–431 (1998).
pubmed: 9545219 doi: 10.1126/science.280.5362.427
Dong, F., Zhang, L., Hao, F., Tang, H. & Wang, Y. Systemic responses of mice to dextran sulfate sodium-induced acute ulcerative colitis using
pubmed: 23651354 doi: 10.1021/pr4002383
Smedley, J. et al. Tracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmission. PLoS ONE 9, e92830 (2014).
pubmed: 24667371 pmcid: 3965472 doi: 10.1371/journal.pone.0092830
Birse, K. M. et al. Unbiased proteomics analysis demonstrates significant variability in mucosal immune factor expression depending on the site and method of collection. PLoS ONE 8, e79505 (2013).
pubmed: 24244515 pmcid: 3828359 doi: 10.1371/journal.pone.0079505
Bruderer, R. et al. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol. Cell. Proteom. 14, 1400–1410 (2015).
doi: 10.1074/mcp.M114.044305
UniProt Consortium T. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 46, 2699 (2018).
pubmed: 29425356 pmcid: 5861450 doi: 10.1093/nar/gky092
Choi, M. et al. MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinformatics 30, 2524–2526 (2014).
doi: 10.1093/bioinformatics/btu305
Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
doi: 10.1038/nprot.2008.211
Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
pubmed: 10592173 pmcid: 10592173 doi: 10.1093/nar/28.1.27
Tenebaum, D. KEGGREST: Client-Side REST Access to KEGG. R package version 1.24.0 (2019). http://bioconductor.org/packages/release/bioc/html/KEGGREST.html .

Auteurs

Peter McQueen (P)

Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.
National HIV and Retrovirology Labs, JC Wilt Centre for Infectious Diseases, Public Health Agency of Canada, Winnipeg, MB, Canada.

Kathleen Busman-Sahay (K)

Vaccine and Gene Therapy Institute at Oregon Health and Science University, Beaverton, OR, USA.

Florian Rieder (F)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

Laura Noël-Romas (L)

Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.
National HIV and Retrovirology Labs, JC Wilt Centre for Infectious Diseases, Public Health Agency of Canada, Winnipeg, MB, Canada.

Stuart McCorrister (S)

Mass Spectrometry and Proteomics Core Facility, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Garrett Westmacott (G)

Mass Spectrometry and Proteomics Core Facility, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Jacob D Estes (JD)

Vaccine and Gene Therapy Institute at Oregon Health and Science University, Beaverton, OR, USA.
Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.

Adam Burgener (A)

Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada. Adam.Burgener@umanitoba.ca.
National HIV and Retrovirology Labs, JC Wilt Centre for Infectious Diseases, Public Health Agency of Canada, Winnipeg, MB, Canada. Adam.Burgener@umanitoba.ca.
Department of Obstetrics and Gynecology, University of Manitoba, Winnipeg, MB, Canada. Adam.Burgener@umanitoba.ca.
Unit of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden. Adam.Burgener@umanitoba.ca.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH